Cano Health, Inc.
NYSE:CANO
2.3 (USD) • At close February 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 788.073 | 766.746 | 866.909 | 680.373 | 665.028 | 689.373 | 704.337 | 492.255 | 526.798 | 393.163 | 280.135 | 261.939 | 263.133 | 171.206 |
| Cost of Revenue
| 772.469 | 826.386 | 776.758 | 573.372 | 553.432 | 593.964 | 596.456 | 422.011 | 437.024 | 335.598 | 229.333 | 212.625 | 216.034 | 134.594 |
| Gross Profit
| 15.604 | -59.64 | 90.151 | 107.001 | 111.596 | 95.409 | 107.881 | 70.244 | 89.774 | 57.565 | 50.802 | 49.314 | 47.099 | 36.612 |
| Gross Profit Ratio
| 0.02 | -0.078 | 0.104 | 0.157 | 0.168 | 0.138 | 0.153 | 0.143 | 0.17 | 0.146 | 0.181 | 0.188 | 0.179 | 0.214 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 96.473 | 96.587 | 111.765 | 0 | 96.587 | 157.509 | 75.926 | 46.574 | 35.286 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 11.24 | 0 | 0 | 0 | -64.162 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 80.821 | 99.418 | 96.473 | 107.827 | 111.765 | 106.179 | 96.587 | 93.347 | 75.926 | 46.574 | 35.286 | 33.728 | 27.391 | 21.859 |
| Other Expenses
| -0.9 | 1.323 | 27.221 | 26.421 | 25.343 | 19.836 | 19.036 | 0.006 | -0.029 | -0.025 | 5.846 | -0.3 | 5.379 | -0.15 |
| Operating Expenses
| 107.561 | 188.669 | 123.694 | 134.248 | 137.108 | 126.015 | 115.623 | 112.042 | 92.881 | 54.519 | 41.132 | 39.486 | 32.77 | 25.836 |
| Operating Income
| -466.919 | -245.634 | -33.543 | -26.418 | -25.154 | -30.606 | -7.741 | -42.258 | -9.635 | -13.328 | 0.869 | -3.328 | 6.613 | -4.911 |
| Operating Income Ratio
| -0.592 | -0.32 | -0.039 | -0.039 | -0.038 | -0.044 | -0.011 | -0.086 | -0.018 | -0.034 | 0.003 | -0.013 | 0.025 | -0.029 |
| Total Other Income Expenses Net
| -24.923 | -26.983 | -27.042 | -404.662 | -81.814 | 16.851 | 12.451 | 43.077 | -30.701 | 16.252 | -10.625 | -86.1 | -17.404 | -10.927 |
| Income Before Tax
| -491.842 | -272.617 | -60.585 | -300.209 | -113.259 | -13.755 | 0.995 | 1.279 | -40.336 | 2.924 | -9.756 | -46.418 | -10.791 | -11.005 |
| Income Before Tax Ratio
| -0.624 | -0.356 | -0.07 | -0.441 | -0.17 | -0.02 | 0.001 | 0.003 | -0.077 | 0.007 | -0.035 | -0.177 | -0.041 | -0.064 |
| Income Tax Expense
| -0.145 | -1.872 | -32.435 | 1.516 | -1.248 | 0.809 | 1.08 | 0.776 | 0.547 | -2.023 | 0.714 | 0.357 | 0.326 | -0.019 |
| Net Income
| -260.487 | -140.753 | -28.15 | -301.725 | -112.011 | -14.564 | -0.085 | 0.661 | -14.637 | 9.48 | -10.47 | -46.775 | -11.117 | -10.986 |
| Net Income Ratio
| -0.331 | -0.184 | -0.032 | -0.443 | -0.168 | -0.021 | -0 | 0.001 | -0.028 | 0.024 | -0.037 | -0.179 | -0.042 | -0.064 |
| EPS
| -91.87 | -26.67 | -5.59 | -124.58 | -48.22 | -3.07 | -0.018 | 0.37 | -8.57 | 5.67 | -6.3 | 0 | -6.69 | -6.61 |
| EPS Diluted
| -91.87 | -26.67 | -5.59 | -124.58 | -48.22 | -3.07 | -0.018 | 0.37 | -8.57 | 5.61 | -6.3 | 0 | -6.69 | -6.61 |
| EBITDA
| -263.538 | -219.644 | -5.881 | -0.826 | -104.367 | -10.517 | 11.295 | -20.069 | -9.371 | 1.155 | -1.685 | 15.367 | -0.236 | -0.078 |
| EBITDA Ratio
| -0.084 | -0.286 | -0.007 | 0 | 0 | -0.015 | 0.016 | -0.047 | 0.026 | 0.028 | 0.055 | 0.059 | 0.075 | 0.086 |